Galectin Therapeutics Inc [GALT] stock prices are up 6.03% to $2.11 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The GALT shares have gain 3.18% over the last week, with a monthly amount drifted -27.24%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Galectin Therapeutics Inc [NASDAQ: GALT] stock has seen the most recent analyst activity on August 13, 2020, when H.C. Wainwright reiterated its Buy rating and also boosted its price target to $12 from $9. Previously, B. Riley FBR started tracking the stock with Buy rating on February 13, 2019, and set its price target to $11. On December 07, 2017, H.C. Wainwright reiterated its Buy rating and revised its price target to $10 on the stock. H.C. Wainwright reiterated its Buy rating and increased its price target to $6 on November 28, 2017. ROTH Capital initiated its recommendation with a Buy. H.C. Wainwright upgraded its rating to Buy for this stock on March 30, 2017, but kept the price target unchanged to $3.50. In a note dated October 03, 2016, FBR & Co. downgraded an Mkt Perform rating on this stock and revised its target price from $12 to $2.
The stock price of Galectin Therapeutics Inc [GALT] has been fluctuating between $1.55 and $4.27 over the past year. Galectin Therapeutics Inc [NASDAQ: GALT] shares were valued at $2.11 at the most recent close of the market.
Analyzing the GALT fundamentals
Gross Profit Margin for this corporation currently stands at 0.66% with Operating Profit Margin at -494.57%, Pretax Profit Margin comes in at -563.46%, and Net Profit Margin reading is -563.46%. To continue investigating profitability, this company’s Return on Assets is posted at -1.56, Equity is 0.59 and Total Capital is -10.65. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-1.13.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.98 points at the first support level, and at 1.85 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.22, and for the 2nd resistance point, it is at 2.33.
Ratios To Look Out For
It’s worth pointing out that Galectin Therapeutics Inc [NASDAQ:GALT]’s Current Ratio is 1.13. On the other hand, the Quick Ratio is 1.13, and the Cash Ratio is 1.07.
Transactions by insiders
Recent insider trading involved ELDRED KARY, Director, that happened on Oct 23 ’24 when 500.0 shares were purchased. Director, FREEMAN KEVIN D completed a deal on Oct 17 ’24 to buy 1300.0 shares. Meanwhile, Director FREEMAN KEVIN D bought 5000.0 shares on Oct 16 ’24.
